Cargando…
A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2
Immunization against viral pathogens is generally directed toward the induction of virus neutralizing antibody (VNA) and the maintenance of the potential for a second-set (IgG) response. Indeed, an elevated level of specific antibody is considered a reliable clinical indicator that a state of immuni...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188522/ https://www.ncbi.nlm.nih.gov/pubmed/3029270 |
Ejemplares similares
-
A Novel High-Intensity Focused Ultrasound-Treated Herpes Simplex Virus 2 Vaccine Induces Long-Term Protective Immunity against Lethal Challenge in Mice
por: Xiao, Juhua, et al.
Publicado: (2020) -
Preventive Vaccination with Mesenchymal Stem Cells Protects Mice from Lethal Infection Caused by Herpes Simplex Virus 1
por: Klimova, R. R., et al.
Publicado: (2021) -
Herpes Simplex Virus Infection in Pregnancy
por: Straface, Gianluca, et al.
Publicado: (2012) -
Palate herpes simplex virus infection
por: Mosaico, Giovanna, et al.
Publicado: (2020) -
T Cell Receptor–γ/δ Cells Protect Mice from Herpes Simplex Virus Type 1–induced Lethal Encephalitis
por: Sciammas, Roger, et al.
Publicado: (1997)